The company, which develops, markets and sells athlete-focused nutritional supplements, reported net sales were up, to $50.2 million from $22.6 million during the year ago quarter.
Net income for the 2014 first quarter was $2.7 million, or 23 cents per diluted share, compared with a net loss of $7.4 million, or $1.78 per share for the 2013 first quarter.
Must Read: Warren Buffett's 10 Favorite Growth Stocks
STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.
STOCKS TO BUY: TheStreet's Stocks Under $10 has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.